halothane has been researched along with pyrroles in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crippen, GM; Ghose, AK | 1 |
| Nagasaka, H; Yaksh, TL | 1 |
| Larach, DR; Schuler, HG | 1 |
| Murray, PA; Nakayama, M; Sato, K; Seki, S | 1 |
| Barberá, M; Cortijo, J; Higueras, J; Maruenda, A; Morcillo, EJ; Ortiz, JL; SarrÃa, B | 1 |
| Horibe, M; Murray, PA; Seki, S | 1 |
6 other study(ies) available for halothane and pyrroles
| Article | Year |
|---|---|
Use of physicochemical parameters in distance geometry and related three-dimensional quantitative structure-activity relationships: a demonstration using Escherichia coli dihydrofolate reductase inhibitors.
Topics: Binding Sites; Escherichia coli; Folic Acid Antagonists; Models, Molecular; Protein Conformation; Structure-Activity Relationship | 1985 |
Effects of intrathecal mu, delta, and kappa agonists on thermally evoked cardiovascular and nociceptive reflexes in halothane-anesthetized rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Anesthesia, Inhalation; Animals; Blood Pressure; Dose-Response Relationship, Drug; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Methionine; Enkephalins; Halothane; Heart Rate; Hot Temperature; Injections, Spinal; Male; Morphine; Nalbuphine; Nociceptors; Pain Threshold; Pyrroles; Pyrrolidines; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Opioid; Reflex; Thiophenes | 1995 |
Potassium channel blockade and halothane vasodilation in conducting and resistance coronary arteries.
Topics: Animals; Benzopyrans; Coronary Vessels; Cromakalim; Endothelium, Vascular; Glyburide; Halothane; In Vitro Techniques; Muscle, Smooth, Vascular; Potassium Channel Blockers; Potassium Channels; Pyrroles; Rats; Tetraethylammonium Compounds; Vasodilation | 1993 |
Halothane and enflurane attenuate pulmonary vasodilation mediated by adenosine triphosphate-sensitive potassium channels compared to the conscious state.
Topics: Adenosine Triphosphate; Anesthetics, Inhalation; Animals; Benzopyrans; Consciousness; Cromakalim; Dogs; Dose-Response Relationship, Drug; Enflurane; Glyburide; Halothane; Male; Potassium Channels; Pulmonary Circulation; Pyrroles; Vasodilation | 1997 |
Halothane inhibits endothelium-dependent relaxation elicited by acetylcholine in human isolated pulmonary arteries.
Topics: Acetylcholine; Adenylyl Cyclases; Anesthetics, Inhalation; Benzopyrans; Colforsin; Cromakalim; Drug Evaluation, Preclinical; Endothelium, Vascular; Enzyme Activation; Guanylate Cyclase; Halothane; Humans; Immunoglobulin E; In Vitro Techniques; Nitroprusside; Pulmonary Artery; Pyrroles; Vasodilator Agents | 1997 |
Halothane attenuates endothelium-dependent pulmonary vasorelaxant response to lemakalim, an adenosine triphosphate (ATP)-sensitive potassium channel agonist.
Topics: Adenosine Triphosphate; Anesthetics, Inhalation; Animals; Benzopyrans; Cromakalim; Dogs; Endothelium, Vascular; Glyburide; Halothane; Humans; Indomethacin; Muscle, Smooth, Vascular; NG-Nitroarginine Methyl Ester; Potassium Channels; Pulmonary Artery; Pyrroles; Vasodilation; Vasodilator Agents | 1997 |